Retinal findings in pediatric patients with Usher syndrome Type 1 due to mutations in MYO7A gene

Olaia Subirà1, Jaume Català-Mora2,3, Jesús Díaz-Cascajosa3

  • 1Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. osubira@bellvitgehospital.cat.

Eye (London, England)
|July 20, 2019
PubMed

Insights

Swept-source optical coherence tomography (SS-OCT) reveals outer retinal layer damage, particularly in photoreceptors, as a key feature of early Usher syndrome type 1 (USH1). This damage correlates with vision loss and may lead to inner retinal changes like cystoid macular edema.

Area of Science:

  • Ophthalmology
  • Genetics
  • Medical Imaging

Background:

  • Usher syndrome type 1 (USH1) is a genetic disorder causing vision and hearing loss.
  • Early detection of retinal changes is crucial for managing USH1.

Purpose of the Study:

  • To characterize retinal alterations in pediatric USH1 patients using swept-source optical coherence tomography (SS-OCT).
  • To compare SS-OCT findings with existing literature on USH1 retinal pathology.

Main Methods:

  • SS-OCT (1050 nm) was performed on 32 eyes from 16 pediatric USH1 patients (ages 4-17) with MYO7A mutations.
  • Macular structural abnormalities were analyzed and correlated with best-corrected visual acuity (BCVA).

Main Results:

  • External limiting membrane, myoid, and ellipsoid zones showed high rates of disruption (84.4-87.5%).
  • Outer segment loss was observed in 90.6% of eyes; retinal pigment epithelium damage varied.
  • Cystoid macular edema (CMO) correlated with photoreceptor alterations; myoid/ellipsoid zone disruption independently predicted decreased BCVA.

Conclusions:

  • Early-stage USH1 pathology likely involves outer retinal layer and photoreceptor changes.
  • These outer retinal changes may precipitate inner retinal alterations, including CMO.
  • Monitoring photoreceptor integrity is recommended for early detection of USH1 progression.
Abstract

Related Concept Videos

Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
62.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Mutations01:39

Mutations

Overview
94.4K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
43.8K